Articles for tag: 2025, bengaluru, domestic help, funding, house-help, India, lachy groom, on-demand service, pronto, startup, tech investment, valuation

Olivia D

Lachy Groom Backs India Startup Pronto at $200M Valuation

Pronto Set to Double Valuation to $200 Million with New Funding Round In an exciting development for the Indian startup scene, Pronto, an instant house-help service, is on the verge of completing a funding round led by tech investor Lachy Groom. This new investment is expected to boost Pronto’s valuation to approximately $200 million, doubling ...

Olivia D

Waabi Secures $1B to Launch Robotaxis with Uber

Waabi Secures $1 Billion to Venture into Robotaxi Market with Uber Partnership Autonomous vehicle startup Waabi has made headlines by raising $1 billion, enabling the company to expand its focus beyond autonomous trucking into the world of robotaxis. This significant funding includes a robust $750 million Series C round, co-led by Khosla Ventures and G2 ...

Olivia D

Synthesia Reaches $4B Valuation: Employee Cash-Out Offer

Synthesia Soars: British Startup Raises $200 Million and Doubles Valuation British startup Synthesia has made headlines by securing $200 million in a Series E funding round, raising its impressive valuation to $4 billion. Remarkably, this is a significant leap from last year’s valuation of $2.1 billion. Pioneering AI in Corporate Training Synthesia is not just ...

Olivia D

Harvey Acquires Hexus: Legal Tech Competition Intensifies

Harvey Acquires Hexus in Strategic Move to Boost Legal AI Innovation In a significant development in the legal tech arena, Harvey, a trailblazing legal AI startup, has successfully acquired Hexus, a burgeoning company known for its innovative tools that create product demos, videos, and guides. This acquisition aligns with Harvey’s strategy to enhance its offerings ...

Olivia D

Converge Bio Secures $25M Funding Led by Bessemer & Tech Executives

AI Revolutionizes Drug Discovery: Converge Bio Secures $25 Million Funding Artificial intelligence (AI) is rapidly reshaping the landscape of drug discovery as pharmaceutical and biotech firms seek to accelerate research and development timelines along with increasing the success rate in a challenging economic environment. Over 200 startups are now vying to integrate AI into their ...